Molecular diagnosis in HAP/VAP

Current Opinion in Critical Care

Volumn 18, Issue 5, 2012, Pages 487-494

  Lung, Mayli ^a   Codina, Gema ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Bacterial pneumonia; Diagnosis; Hospital acquired pneumonia; Methods; Molecular; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC RESISTANCE; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; HOSPITAL ACQUIRED PNEUMONIA; MICROBIAL IDENTIFICATION; MOLECULAR DIAGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; STAPHYLOCOCCUS AUREUS; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; IATROGENIC DISEASE; INTENSIVE CARE UNITS; MOLECULAR DIAGNOSTIC TECHNIQUES; PNEUMONIA, VENTILATOR-ASSOCIATED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; ROC CURVE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VENTILATORS, MECHANICAL;

EID: 84865966553     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283577d37     Document Type: Review

References (71)

1. Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008; 62:5-34. (Pubitemid 351865870)
2. Wiener-Kronish JP, Dorr HI. Ventilator-associated pneumonia: problems with diagnosis and therapy. Best Pract Res Clin Anaesthesiol 2008; 22: 437-449.
3. Houck PM, Bratzler DW. Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes? Curr Opin Infect Dis 2005; 18:151-156. (Pubitemid 40380215)
4. Torres A, Ferrer M, Badia J.R. Treatment guidelines and outcomes of hospitalacquired and ventilator-associated pneumonia. Clin Infect Dis 2010; 51 (Suppl 1):S48-S53.
5. Waterer GW, Kessler LA, Wunderink RG. Delayed administration of antibiotics and atypical presentation in community-acquired pneumonia. Chest 2006; 130:11-15. (Pubitemid 44116836)
6. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51 (Suppl 1): S81-S87.
7. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
8. Mothershed EA, Whitney AM. Nucleic acid-based methods for the detection of bacterial pathogens: present and future considerations for the clinical laboratory. Clin Chim Acta 2006; 363:206-220. (Pubitemid 41745237)
9. Murdoch DR, O'Brien KL, Driscoll AJ, et al. Laboratory methods for determining pneumonia etiology in children. Clin Infect Dis 2012; 54 (Suppl 2):S146-S152.
10. Kett DH, Cano E, Quartin AA, et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis 2011; 11: 181-189.
11. Weng L, Hu X, Peng J, et al. Treatment of hospital-acquired pneumonia. Lancet Infect Dis 2011; 11:728-729; author reply 731-722.
12. Spellberg B, Talbot G. Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010; 51 (Suppl 1): S150-170.
13. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903. (Pubitemid 34774654)
14. Sandiumenge A, Rello J. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulm Med 2012; 18:187-193.
15. Gales AC, Castanheira M, Jones RN, Sader HS. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012; 73:354-360.
16. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect 2011; 17 (Suppl 6):E1-E59.
17. Tenover FC. Developing molecular amplification methods for rapid diagnosis of respiratory tract infections caused by bacterial pathogens. Clin Infect Dis 2011; 52 (Suppl 4):S338-S345.
18. Jernigan DB, Lindstrom SL, Johnson JR, et al. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis 2011; 52 (Suppl 1):S36-S43.
19. Murdoch DR. Molecular genetic methods in the diagnosis of lower respiratory tract infections. APMIS 2004; 112:713-727. (Pubitemid 40164011)
20. Bierbaum S, Konigsfeld N, Besazza N, et al. Performance of a novel microarray multiplex PCR for the detection of 23 respiratory pathogens (SYMP-ARI study). Eur J Clin Microbiol Infect Dis 2012. [Epub ahead of print]
21. Lin B, Blaney KM, Malanoski AP, et al. Using a resequencing microarray as a multiple respiratory pathogen detection assay. J Clin Microbiol 2007; 45: 443-452.
22. Miller MB, Tang YW. Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev 2009; 22:611-633.
23. Chen L, Mediavilla JR, Endimiani A, et al. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (blaKPC) variants. J Clin Microbiol 2011; 49:579-585.
24. Emonet S, Shah HN, Cherkaoui A, Schrenzel J. Application and use of various mass spectrometry methods in clinical microbiology. Clin Microbiol Infect 2010; 16:1604-1613.
25. Caliendo AM. Multiplex PCR and emerging technologies for the detection of respiratory pathogens. Clin Infect Dis 2011; 52 (Suppl 4):S326-S330.
26. Endimiani A, Hujer KM, Hujer AM, et al. Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia? Clin Infect Dis 2011; 52 (Suppl 4):S373-S383.
27. Hayden RT, Gu Z, Rodriguez A, et al. Comparison of two broadly multiplexed PCR systems for viral detection in clinical respiratory tract specimens from immunocompromised children. J Clin Virol 2012; 53:308-313.
28. Spencer DH, Sellenriek P, Burnham CA. Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting. Am J Clin Pathol 2011; 136:690-694.
29. Stamper PD, Cai M, Howard T, et al. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J Clin Microbiol 2007; 45:2191-2196. (Pubitemid 47203792)
30. Ho TH, Huang YC, Lin TY. Evaluation of the BD GeneOhm StaphSR assay for detection of Staphylococcus aureus in patients in intensive care units. J Microbiol Immunol Infect 2011; 44:310-315.
31. Wassenberg MW, Kluytmans JA, Bosboom RW, et al. Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens. Clin Microbiol Infect 2011; 17:1704-1710.
32. Wolk DM, Picton E, Johnson D, et al. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol 2009; 47:758-764.
33. Senn L, Basset P, Nahimana I, et al. Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test? Clin Microbiol Infect 2012; 18:E31-E33.
34. Hassan H, Shorman M. Evaluation of the BD GeneOhm MRSA and VanR assays as a rapid screening tool for detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in a tertiary hospital in Saudi Arabia. Int J Microbiol 2011; 2011:861514.
35. Cercenado E, Marín M, Insa R, et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in lower respiratory-tract secretions from patients with ventilator-associated pneumonia: evaluation of the Cepheid Xpert Assay. In Forty-nine ICAAC. San Francisco, CA: September 12-15, 2009. Abstract.
36. Ohl CA, Varela V, White M, et al. Performance of a real-time PCR assay for the detection of methicillin-resistant S. aureus (MRSA) in sputum specimens. In Program and abstracts. Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: September 27-30, 2006. Abstract D-841.
37. Peterson LR. Molecular laboratory tests for the diagnosis of respiratory tract infection due to Staphylococcus aureus. Clin Infect Dis 2011; 52 (Suppl 4): S361-S366.
38. Gray J, Patel M, Turner H, Reynolds F. MRSA screening on a paediatric intensive care unit. Arch Dis Child 2012; 97:243-244.
39. Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multipathogen detection: development and application to respiratory tract infection. PLoS One 2011; 6:e26047.
40. Loeffelholz MJ, Pong DL, Pyles RB, et al. Comparison of the FilmArray Respiratory Panel and Prodesse real-time PCR assays for detection of respiratory pathogens. J Clin Microbiol 2011; 49:4083-4088.
41. Rand KH, Rampersaud H, Houck HJ. Comparison of two multiplex methods for detection of respiratory viruses: FilmArray RP and xTAG RVP. J Clin Microbiol 2011; 49:2449-2453.
42. Drake RR, Boggs SR, Drake SK. Pathogen identification using mass spectrometry in the clinical microbiology laboratory. J Mass Spectrom 2011; 46:1223-1232.
43. Seng P, Rolain JM, Fournier PE, et al. MALDI-TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 2010; 5:1733-1754.
44. Bittar F, Ouchenane Z, Smati F, et al. MALDI-TOF-MS for rapid detection of staphylococcal Panton-Valentine leukocidin. Int J Antimicrob Agents 2009; 34:467-470.
45. Szabados F, Becker K, von Eiff C, et al. The matrix-assisted laser desorption/ ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302 Da are not associated with the presence of Panton-Valentine leukocidin. Int J Med Microbiol 2011; 301:58-63.
46. Seng P, Drancourt M, Gouriet F, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009; 49:543-551.
47. Sparbier K, Schubert S, Weller U, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against beta-lactam antibiotics. J Clin Microbiol 2012; 50:927-937.
48. Dubois D, Grare M, Prere MF, et al. Performances of the MALDI-TOF Mass Spectrometry system VITEK MS for the Rapid Identification of Bacteria in Routine Clinical Microbiology. J Clin Microbiol 2012; 50:2568-2576.
49. Ferreira L, Sanchez-Juanes F, Gonzalez-Avila M, et al. Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2010; 48:2110-2115.
50. Saffert RT, Cunningham SA, Ihde SM, et al. Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J Clin Microbiol 2011; 49:887-892.
51. Marko DC, Saffert RT, Cunningham SA, et al. Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gramnegative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 2012; 50:2034-2039.
52. Xiao D, Zhao F, Lv M, et al. Rapid identification of microorganisms isolated from throat swab specimens of community-acquired pneumonia patients by two MALDI-TOF MS systems. Diagn Microbiol Infect Dis 2012; 73:301-307.
53. Ecker DJ, Sampath R, Massire C, et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008; 6:553-558. (Pubitemid 351850978)
54. Suzuki Y, Suda T, Yokomura K, et al. Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia. J Infect 2011; 63:215-222.
55. Tirone C, Boccacci S, Inzitari R, et al. Correlation of levels of alpha-defensins determined by HPLC-ESI-MS in bronchoalveolar lavage fluid with the diagnosis of pneumonia in premature neonates. Pediatr Res 2010; 68:140-144.
56. Endimiani A, Hujer AM, Hujer KM, et al. Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates. J Clin Microbiol 2010; 48:2618-2622.
57. Hujer KM, Hujer AM, Endimiani A, et al. Rapid determination of quinolone resistance in Acinetobacter spp. J Clin Microbiol 2009; 47:1436-1442.
58. Wolk DM, Blyn LB, Hall TA, et al. Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionizationmass spectrometry and correlation with phenotype. J Clin Microbiol 2009; 47:3129-3137.
59. Wolk DM, Kaleta EJ, Wysocki VH. PCR-electrospray ionization mass spectrometry: the potential to change infectious disease diagnostics in clinical and public health laboratories. J Mol Diagn 2012; 14.
60. Eshoo MW, Crowder CD, Li H, et al. Detection and identification of Ehrlichia species in blood by use of PCR and electrospray ionization mass spectrometry. J Clin Microbiol 2010; 48:472-478.
61. Naas T, Cuzon G, Bogaerts P, et al. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extendedspectrum beta-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. J Clin Microbiol 2011; 49:1608-1613.
62. Wang L, Gu H, Lu X. A rapid low-cost real-time PCR for the detection of Klebsiella pneumonia carbapenemase genes. Ann Clin Microbiol Antimicrob 2012; 11:9.
63. Schuetz AN, Huard RC, Eshoo MW, et al. Identification of a novel Acinetobacter baumannii clone in a US hospital outbreak by multilocus polymerase chain reaction/electrospray-ionization mass spectrometry. Diagn Microbiol Infect Dis 2012; 72:14-19.
64. Mackay IM. Real-time PCR in the microbiology laboratory. Clin Microbiol Infect 2004; 10:190-212.
65. Espy MJ, Uhl JR, Sloan LM, et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev 2006; 19: 165-256. (Pubitemid 43158452)
66. Sethi S. Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 2011; 52 (Suppl 4):S290-S295.
67. Curran T, Coyle PV, McManus TE, et al. Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol 2007; 50:112-118. (Pubitemid 46763475)
68. Isaacs RJ, Debelak K, Norris PR, et al. Noninvasive detection of pulmonary pathogens in ventilator-circuit filters by PCR. Am J Transl Res 2012; 4: 72-82.
69. Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis 2008; 60:255-261. (Pubitemid 351253612)
70. Rello J, Lisboa T, Lujan M, et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009; 136:832-840.
71. Werno AM, Anderson TP, Murdoch DR. Association between pneumococcal load and disease severity in adults with pneumonia. J Med Microbiol 2012; 61:1129-1135.